Pirfenidone Protects from UVB-Induced Photodamage in Hairless Mice.

Yocasta Martinez-AlvaradoEduardo Amezcua-GalvezJudith Davila-RodriguezAna Sandoval-Rodriguez Marina Galicia-MorenoMónica Almeida-LópezSilvia Lucano-LanderosArturo Santos Hugo Christian Monroy-Ramírez Juan Armendáriz-Borunda

Published in: Molecules (Basel, Switzerland) (2023)

Topical pirfenidone represents a promising agent for the treatment of cell photodamage in humans. Clinical trials need to be carried out to explore this premise.

Keyphrases

idiopathic pulmonary fibrosis
clinical trial
single cell
pulmonary fibrosis
high glucose
cell therapy
diabetic rats
type diabetes
stem cells
metabolic syndrome
phase ii
mesenchymal stem cells
replacement therapy
phase iii